Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Tirzepatide for Sale > Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2
Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2 buy - large image1
Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2 buy - image1
Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2 buy - image2
Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2 buy - image3
Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2 buy - image4
Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2 buy - image5
Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2 buy - image6

Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2

2078 Inquiries

Unit Price:

$80-95/UNIT FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

ZhongMa

Packaging:

40/50/60mg/vial; 10vials/box

Price valid (until):

2027-03-05

Company Type:
Trader
Location:
China
Qualification:
Main Products:

GLP-1,Retatrutide,Tirzepatide,Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Sales manager:Una
    whatsapp:+8618830993261
    Email: Una@hzzmtrade.cn


    Wholesale Price 40mg 50mg 60mg Tirzepatide Weight Loss CAS: 2023788-19-2

    Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 1

    Tirzepatide is a peptide-based compound that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has attracted considerable interest in metabolic research because of its effects on glucose regulation, appetite-related pathways, and body-weight management. Clinical studies have shown that Tirzepatide can produce meaningful improvements in glycemic control and body weight in adults with type 2 diabetes.

    In addition to its effects on blood glucose, research has explored the broader metabolic actions of Tirzepatide. Studies suggest that activation of both GIP and GLP-1 receptor pathways may influence insulin secretion, gastric emptying, appetite regulation, and overall energy balance. Ongoing research is also examining its potential relationship with cardiovascular and other metabolic outcomes.

    For approved clinical use, dosage and dose escalation are determined according to the specific indication, individual response, tolerability, and relevant medical factors. Appropriate medical supervision and regular monitoring are important to support safe and effective treatment.

    Items Specifications

    Product Name

    Tirzepatide

    CAS number

    2023788-19-2

    Purity

    99%

    Molecular Weight

    4813.527g/mol

    Molecular Formula

    C225H348N48O68

    Application


    Weight loss

    Appearance

    White Lyophilized powder


    Product Function 

    Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to harness the complementary metabolic effects of both incretin pathways. Activation of the GIP receptor may help modulate some of the gastrointestinal and central nervous system effects associated with GLP-1 receptor stimulation, potentially improving treatment tolerability and supporting effective dose escalation. In addition to its effects on glucose regulation and body weight, post-hoc analyses in individuals with type 2 diabetes have reported favorable changes in several biomarkers associated with non-alcoholic steatohepatitis (NASH), together with increases in adiponectin levels.

    The substantial weight-reducing effect of tirzepatide has also generated considerable interest in understanding its underlying mechanisms. As a combined GIPR and GLP-1R agonist, tirzepatide has demonstrated marked reductions in HbA1c and body weight in people with type 2 diabetes, including greater improvements than those observed with once-weekly semaglutide 1 mg in comparative clinical studies.

    Research into the central mechanisms of GIP signaling suggests that GIP receptors are distributed across multiple regions of both the human and mouse brain, including neuronal and glial populations. Certain cells within the hypothalamus and hindbrain have also been found to express both GIP and GLP-1 receptors. Experimental activation of GIP receptor-expressing cells in the mouse hypothalamus has been shown to acutely reduce food intake. However, combining this stimulation with the GLP-1 receptor agonist exendin-4 did not appear to produce a further additive reduction in food consumption compared with either intervention alone.

    Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 2


    Product Application

    Peptides are short chains of amino acids linked by peptide bonds and are naturally involved in numerous biological processes. Depending on their amino acid sequence and structure, different peptides may function as signaling molecules, metabolic regulators, structural components, or intermediates in protein metabolism.

    From a nutritional and biochemical perspective, peptides can serve as a source of amino acids and may be efficiently utilized during digestion and metabolism. Certain bioactive peptides are also studied for their potential roles in cellular signaling, enzyme regulation, energy metabolism, and tissue maintenance.

    In muscle-related research, peptides and amino-acid-derived compounds are of interest because amino acids are essential components of protein synthesis and tissue repair. Their biological effects, however, vary considerably depending on the specific peptide, concentration, route of exposure, and physiological conditions. Therefore, the properties of individual peptides should be evaluated separately rather than generalized to all peptide compounds.

    Peptides are also widely investigated in areas such as appetite regulation, metabolic signaling, cellular communication, recovery, and general physiological function. The biological activity of a peptide is highly dependent on its molecular structure and intended application, and not all peptides produce the same effects.

    For this reason, peptide products should be selected according to their intended research purpose, purity, analytical documentation, and appropriate handling requirements. Proper storage and laboratory procedures are important for maintaining peptide stability and consistency.

    Peptide Storage & Handling Guidelines

    For general laboratory storage and handling, the following practices may help maintain peptide stability:

    • Store peptides in a cool, dry, and dark environment according to the product-specific storage requirements.
    • Minimize repeated freeze–thaw cycles, which may affect stability.
    • Limit unnecessary exposure to air and moisture.
    • Protect peptide materials from prolonged light exposure.
    • For peptides prepared in liquid form, avoid extended storage unless stability data support it.
    • Where appropriate, divide the material into smaller aliquots based on experimental requirements to reduce repeated handling.

    Important: Storage conditions can differ significantly between individual peptides. Always follow the specific stability information, analytical documentation, and recommended storage conditions provided for the particular product.


    Company Profile

    Our company is a modern enterprise engaged in the development, production, and international supply of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, plant extracts, and related raw materials. Our products serve a wide range of industries, including pharmaceuticals, healthcare products, cosmetics, nutritional supplements, and food-related applications.

    Our manufacturing site covers approximately 95 acres and is designed with an emphasis on standardized production, efficient workflow, and a clean working environment. The planned production facilities are developed in accordance with relevant GMP-oriented standards, with well-organized production areas, processing workshops, quality-control facilities, and research laboratories. Advanced manufacturing and analytical equipment supports product consistency, process control, and quality evaluation throughout production.

    We place strong emphasis on quality management, technical improvement, and professional team development. Modern production equipment and standardized operating procedures help improve manufacturing efficiency and maintain accuracy at different stages of production. Key processes, including production, processing, extraction, packaging, and logistics preparation, are managed through an integrated workflow to support stable quality and efficient order fulfillment.

    Innovation is also an important part of our long-term development. Our technical team continues to explore new raw materials, optimize production processes, and develop products in response to changing market requirements. Through continuous improvement and accumulated industry experience, we have established long-term relationships with customers in multiple international markets.

    Over the years, the company has gained extensive experience in international trade, export services, customer communication, and supply-chain management. A stable customer network and continuously improving service system allow us to provide professional support from product inquiry and order processing to packaging and delivery.

    In addition, we maintain long-term technical exchanges and cooperative relationships with experts, professors, universities, and research institutions, helping us strengthen our research capabilities, improve production technologies, and support the continued development of new products.


    Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 3 Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 4

    Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 5 Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 6

    Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 7


    Why choose us?  

    Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 8


    Transportation methods

    Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 9

    Product Images 

    Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 10 Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 11 Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 12


    Tracking Number
    Shop Best Price Tirzepatide 40mg Peptide Powder High Purity 99% Wholesale Bulk Supply CAS 2023788-19-2-Detailed Image 13


    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,Retatrutide,Tirzepatide,Peptides

    Location:

    Room A008, 704#, Building 11, Shiliu Street Block, Liangzhu Subdistrict, Yuhang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

  • Inquiry History
    2078 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    Poland

    TIRZEPATIDE

    10 MG Feb 18, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.